Impact Factor
4.30
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.63
4,281 total citations
h5-index
69
h5 depth signal
Cited share
81.6%
639 of 783
Total citations
4,281
Citation footprint
Metric signal
5.76
External metric anchor
Self-citation
10.4%
447 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,773
United Kingdom
527
Germany
494
Italy
482
Australia
467
Citing Fields of Research
Brain Neurological Disorders
3,506
Neurosciences
518
Neurodegenerative Disorders
115
Cytogenetics
86
Brain Imaging
83
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
16,967
Articles tracked across the journal lifetime
Indexed publication set
783
639 cited publications
Last 12 months
574
47.8 publications/month
Open access share
60.5%
347 OA publications in the last year
Leading citing country
United States
1,773 citing publications
Leading citing field
Brain Neurological Disorders
3,506 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v6n3,Sept. 1965-
v6n3,Sept. 1965-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Brain Neurological Disorders
Issuing & Sponsoring Bodies
Contributor
International League against Epilepsy
Broad Categories
Brain
Neurology
Brain Neurological Disorders
MeSH Descriptors
Epilepsy
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/epi.70547
Open DOI
Artificial intelligence‐assisted categorization of interictal abnormalities in adult long‐term electroencephalographic monitoring: Comparable diagnostic accuracy with marked efficiency gain
Objective: Artificial intelligence (AI) classifies routine electroencephalograms (EEGs) with expert‐level accuracy, but interpretation of long‐term EEG monitoring (LTM) remains reliant on time‐intensive visual review. We evaluated whethe...
02
DOI 10.1002/epi.70529
Open DOI
Multimodal modeling of the ictal onset zone in refractory insular epilepsy and seizure outcome of magnetic resonance‐guided laser interstitial therapy: A pediatric single‐center retrospective study
Objective: This study was undertaken to evaluate seizure outcomes after magnetic resonance‐guided laser interstitial thermal therapy (MRgLITT) in children with insular epilepsy and to assess how the extent of ablation overlaps with multi...
03
DOI 10.1002/epi.70556
Open DOI
Issue Information
04
DOI 10.1002/epi.70531
Open DOI
Epilepsia —October 2026 announcements
05
DOI 10.1002/epi.70548
Open DOI
Frequent involvement of cingulate and insulo‐opercular regions in sleep‐related hypermotor epilepsy: A multimodal presurgical study
Objective: Sleep‐related hypermotor epilepsy (SHE) is classically considered a frontal lobe epilepsy; however, accumulating evidence suggests that hypermotor seizures may arise from multiple frontal and extrafrontal regions. We character...
06
DOI 10.1002/epi.70501
Open DOI
Beyond seizure control: Non–seizure‐related outcomes in focal‐onset epilepsy treated with adjunctive cenobamate. Third interim results from the BLESS study
Objective: Cenobamate is approved for treatment of focal seizures in adults, but evidence on non‐seizure outcomes remains limited. This interim statistical analysis of the cenoBamate in aduLts with focal‐onsEt SeizureS (BLESS) study eval...
07
DOI 10.1002/epi.70546
Open DOI
Impact of sedation on the reliability of magnetoencephalographic language mapping in pediatric epilepsy
Objective: Magnetoencephalography (MEG) language mapping in pediatric epilepsy frequently requires sedation, which may alter cortical physiology and compromise the reliability of language lateralization. We hypothesized that sedation dis...
08
DOI 10.1002/epi.70437
Open DOI
Change in clobazam pharmacokinetics after introduction of cenobamate
Cenobamate is a new antiseizure medication with an unusually high seizure‐free rate, resulting in frequent use in patients with drug‐resistant epilepsy. Many of these patients are taking clobazam (CLB) at baseline. Cenobamate has importa...
09
DOI 10.1002/epi.70515
Open DOI
Limited sex‐specific structural alterations across common epilepsies: A worldwide ENIGMA study
Objective: Epilepsy is characterized by widespread cortical and subcortical structural alterations beyond the epileptic zone. Importantly, the clinical manifestation of epilepsy, including seizure types, psychiatric comorbidities, and tr...
10
DOI 10.1002/epi.70536
Open DOI
Fenfluramine treatment and seizure‐free days in pediatric and adult patients with Lennox–Gastaut syndrome: A post hoc analysis
The most common primary endpoint for assessing treatment efficacy in patients with Lennox–Gastaut syndrome (LGS) is change in frequency of seizures associated with a fall. Increased number of seizure‐free days (SFDs) is more strongly ass...
Bibliographical & Catalog Notes
Publication suspended Nov. 1915-Feb. 1937.
Vol. 32, Suppl. 4 not published.
Supplements accompany some vols., 1982?- .
Also issued online.
Microfilm. v. 1 (1909)-5 (1915), ser. 2: v. 1 (1937)-4 (1950). 4 microfilm reels : negative ; 35 mm.
Text in English; some summaries in English and French.
Issued by the International League against Epilepsy.
Sister publication to: Epilepsia open.
Vol. 26, no. 1 (JAN-FEB 1985)19900914 Notice not published Printed on acid-free paper